If one investigates the profound positives that psilocybin offers many neurological illnesses, TRP-8803 will be a game changer once this drug becomes standard care, this is because it's the only way the drug can be confidently and safely administered to patients.
- Forums
- ASX - By Stock
- TYP
- Ann: Maiden dosing of TRP-8803 completed in global first
Ann: Maiden dosing of TRP-8803 completed in global first, page-3
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TYP (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.3¢ |
Change
0.001(3.13%) |
Mkt cap ! $35.93M |
Open | High | Low | Value | Volume |
3.2¢ | 3.4¢ | 3.2¢ | $186.3K | 5.674M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 8742 | 3.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.4¢ | 217109 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 1728388 | 0.032 |
5 | 2387580 | 0.031 |
17 | 4815287 | 0.030 |
3 | 418965 | 0.029 |
2 | 1250000 | 0.028 |
Price($) | Vol. | No. |
---|---|---|
0.034 | 195109 | 2 |
0.035 | 250000 | 1 |
0.037 | 1003334 | 3 |
0.038 | 500000 | 1 |
0.039 | 502810 | 2 |
Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
Featured News
TYP (ASX) Chart |